echoloc

Protagonist Therapeutics Tech Stack

Peptide drug discovery platform targeting oral bioavailability and GLP-1 class therapeutics

Biotechnology Newark, California 51–200 employees Founded 2006 Public Company

Protagonist is a public biotech company using a proprietary peptide-engineering platform to develop oral drugs in areas like metabolic disease and GI disorders. The tech stack reveals a mature, multi-modal development operation: HPLC-MS, LC-MS/MS, NONMEM, and Phoenix WinNonlin for pharmacokinetics; GraphPad Prism and Spotfire for data analysis; plus cloud infrastructure (AWS, Azure, GCP) and active AI/ML adoption (GPT, Gemini, MCP). The hiring velocity is accelerating with 17 roles posted in the last 30 days—60% research-heavy—and projects spanning solid-dose formulation, manufacturing scale-up, and clinical supply, signaling movement from discovery into late-stage development and manufacturing readiness.

Tech Stack 24 technologies

Core StackZoom Intune AWS Python MATLAB macOS iOS NinjaOne Freshservice HPLC-MS GraphPad Prism GPT Gemini Azure GCP MCP HPLC LIMS ChemDraw SciFinder Spotfire LC-MS/MS Phoenix WinNonlin NONMEM

What Protagonist Therapeutics Is Building

Challenges

  • Scale up clinical supply manufacturing
  • Meeting regulatory cmc requirements
  • Optimizing peptide oral delivery
  • Adopting ai at scale
  • Ensuring ai security compliance
  • Embedding ai into workflows
  • Improving study processes
  • Recruitment challenges
  • Managing vendor risk
  • Ensuring trial timelines

Active Projects

  • In vivo pharmacology studies
  • Solid oral dosage form development
  • Automated data pipelines
  • Scalable manufacturing process development
  • Pk/pd evaluation of drug candidates
  • Ai-driven solution prototyping
  • Enterprise ai deployment
  • Clinical supply manufacturing
  • Clinical study milestones
  • Site recruitment strategy

Hiring Activity

Accelerating15 roles · 15 in 30d

Department

Research
10
Healthcare
2
HR
2
Engineering
1
IT
1
Legal
1

Seniority

Senior
7
Mid
4
Director
3
Staff
3
Company intelligence

Find more companies like Protagonist Therapeutics by tech stack, pain points and active projects

Get started free

About Protagonist Therapeutics

Protagonist Therapeutics (Nasdaq: PTGX) is a public biopharmaceutical company focused on peptide-based drug discovery and development. Founded in 2006 and headquartered in Newark, California, the company operates a proprietary platform for de novo peptide discovery with engineered oral stability through peptidomimetic and chemical modifications. The 51–200 person team is currently executing across in vivo pharmacology studies, pharmacokinetic/pharmacodynamic evaluations, solid oral dosage form development, and clinical supply manufacturing. Active challenges include scaling manufacturing to meet regulatory chemistry, manufacturing, and controls (CMC) requirements; optimizing peptide oral delivery; and managing clinical trial recruitment and timelines.

HeadquartersNewark, California
Company Size51–200 employees
Founded2006
Hiring MarketsUnited States

Frequently Asked Questions

What is Protagonist Therapeutics' technology platform?

Protagonist uses a proprietary platform for discovering peptides de novo with tailored potency, specificity, and selectivity, then engineers oral stability via peptidomimetic and chemical modifications to create oral peptide drugs.

What tech stack does Protagonist use for drug development?

HPLC-MS, LC-MS/MS, NONMEM, Phoenix WinNonlin, GraphPad Prism, Spotfire, ChemDraw, SciFinder, and cloud platforms (AWS, Azure, GCP). Also actively adopting GPT, Gemini, and MCP for AI-driven analysis and prototyping.

Similar Companies in Biotechnology

Other companies in the same industry, closest in size

How this profile is built

Protagonist Therapeutics's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.